Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 8/2002

01-11-2002 | Originales

Non-Hodgkin’s lymphoma in the elderly. Age is not always an adverse prognostic factor

Authors: Ángel Segura Huerta, José Gómez-Codina, Miguel Pastor Borgoñón, Ana Yuste Izquierdo, Pedro López-Tendero, Regina Gironés Sarrió, José A. Pérez-Fidalgo, Constantino Herranz Fernández

Published in: Clinical and Translational Oncology | Issue 8/2002

Login to get access
Metadata
Title
Non-Hodgkin’s lymphoma in the elderly. Age is not always an adverse prognostic factor
Authors
Ángel Segura Huerta
José Gómez-Codina
Miguel Pastor Borgoñón
Ana Yuste Izquierdo
Pedro López-Tendero
Regina Gironés Sarrió
José A. Pérez-Fidalgo
Constantino Herranz Fernández
Publication date
01-11-2002
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 8/2002
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02719121

Other articles of this Issue 8/2002

Clinical and Translational Oncology 8/2002 Go to the issue

Original Breve

Advanced disease and breast reconstruction

Originales

Prognostic factors in recurrent endometrial carcinoma

Notas Clínicas

Increased levels of serum CA-125 antigen in patients with non-Hodgkin’s lymphoma

Announcement

Información

Notas clínicas

Carcinoma de células en anillo de sello del párpado tratado con radioterapia exclusiva

Revisiones

Carcinoma de células de Merkel. Revisión de una neoplasia agresia y controvertida
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits